The largest database of trusted experimental protocols

3 protocols using cgp 57380

1

Comprehensive Pharmacological Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following 43 reagents were used in this study: AMG 102 and panitumumab (Amgen); cercosporamide (BioAustralis); AKT inhibitor V (Calbiochem); AS-252424, bisindolylmaleimide, CGP 57380 and imatinib (Cayman Chemical); CTX ILK inhibitor (CRC); Avastin (bevacizumab) (Genentech/Roche); 4EGI-1, ABT-737, ABT-737 enantiomer, pazopanib, and retinoic acid (Santa Cruz Biotechnology); erlotinib, lapatinib, sorafenib, and temsirolimus (Scientifix); bortezomib and CYT387 (Selleck Chemicals); AKT-I-1/2, axitinib, bicalutamide, cilostazol, cyclopamine, DAPT, dasatinib, docetaxel, doxorubicin, floxuridine, fluorouracil, goserelin, ifosfamide, PD98059, ribavirin, salinomycin, SU11274, sunitinib, Tamoxifen, and vinblastine (Sigma); NSC 7908 (Tocris); and temozolomide (Wyeth).
+ Open protocol
+ Expand
2

Exogenous CDH1 Expression in CHO Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were cultured in high-glucose Dulbecco’s Modified Eagle Medium (DMEM, Merck, Darmstadt, Germany), and CHO-K1 (CHO) cells in DMEM/F-12 (Merck). Both cell culture media were supplemented with 10% fetal bovine serum, 2 mM l-glutamine, and 1% penicillin/streptomycin (all Thermo Fisher Scientific). Transfection of generated CDH1 expression constructs was done using the Lipofectamine 3000 reagent (Thermo Fisher Scientific). For stable expression, transfected CHO cells were treated with 20 µg/ml puromycin (Thermo Fisher Scientific) for 21 days. GFP-positive cells were isolated using a MoFlo XDP cell sorter (Beckman-Coulter, Brea, MA, USA). To inhibit MAPK interacting serine/threonine kinase 1 (MNK1), HEK293T and CHO cells were treated with 75 or 200 µM CGP 57380 (Cayman Chemicals, Ann Arbor, MI, USA) for 24 or 72 h.
+ Open protocol
+ Expand
3

Compound-based Cell Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds and growth factors used to treat cells were: Rapamycin, TGFβ, HGF (EMD Millipore, Billerica, MA), Activin (eBioscience, San Diego, CA), BMP4, Nodal, Torin1 (R&D Systems, Minneapolis, MN), Insulin, Transferrin, and Selenium (ITS) (Roche, San Francisco, CA), SU11274, AG490 (Sigma Aldrich, St. Louis, MO), and CGP57380 (Cayman Chemicals, Ann Arbor, MI). U0126 was obtained from Promega (Madison, WI). A TGFβ Type I Receptor kinase inhibitor (616451) was purchased from EMD Millipore (Billerica, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!